×
About 3,248 results

ALLMedicine™ Hemoptysis Center

Research & Reviews  1,137 results

Glottic Cancer
https://emedicine.medscape.com/article/853055-overview

Dec 3rd, 2021 - Practice Essentials Glottic cancer is a malignancy of the larynx that involves the true vocal cords and anterior and posterior commissures. Because of its anatomic location, it can have profound effects on the basic vital functions, including brea...

Glottic Cancer
https://emedicine.medscape.com/article/853055-print

Dec 3rd, 2021 - Practice Essentials Glottic cancer is a malignancy of the larynx that involves the true vocal cords and anterior and posterior commissures. Because of its anatomic location, it can have profound effects on the basic vital functions, including brea...

Is There Any Role of Pulmonary Endarterectomy in Pulmonary Arterial Hydatidosis?
https://doi.org/10.1016/j.athoracsur.2021.10.035
The Annals of Thoracic Surgery; Erkilinç A, Ermerak NO et. al.

Nov 30th, 2021 - Hydatid Cyst is a zoonosis caused by Echinococcus granulosis. Pulmonary artery involvement is a rare condition. The aim of this study was to review our experience in the surgical treatment of pulmonary arterial hydatidosis. Data were collected pro...

Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculi...
https://doi.org/10.1007/s10067-021-05964-5 10.1002/art.37715 10.1016/j.ejim.2015.04.022 10.1056/NEJMoa1108735 10.1136/annrheumdis-2015-208073 10.1136/ard.2006.054593 10.1111/ijcp.13431 10.1097/RHU.0000000000001529 10.1016/S0140-6736(89)91273-7 10.1038/ki.1990.48 10.1016/s0025-6196(12)62575-0 10.1016/j.semarthrit.2017.12.002 10.1016/j.jbspin.2021.105133 10.1183/09031936.00019210 10.1164/rccm.201308-1483ST 10.1164/rccm.201807-1255ST 10.1148/radiol.2462070712 10.1136/ard.2008.101279 10.1038/ki.2013.444 10.1136/annrheumdis-2018-214263 10.1136/bmjopen-2020-041405 10.1159/000502099 10.21037/jtd.2018.03.120 10.1002/art.39786 10.1002/art.39812 10.1007/s00296-014-3106-z 10.3899/jrheum.190313 10.1136/bmjresp-2014-000058 10.1378/chest.07-1948 10.1164/ajrccm.164.9.2105083 10.1016/S2213-2600(20)30504-X 10.1002/art.34619 10.1016/j.autrev.2020.102618 10.3899/jrheum.161224 10.1378/chest.08-208 10.1053/j.ajkd.2003.08.015 10.1186/s12890-020-01181-z 10.1056/NEJMoa1803537 10.1016/j.jaut.2019.102338 10.1056/NEJMoa1908681 10.1111/crj.13032 10.1183/09031936.98.12051010 10.1371/journal.pone.0073774 10.1164/rccm.200607-912OC 10.26442/terarkh201890615-21 10.3899/jrheum.200721
Clinical Rheumatology; Yang S, Chai D et. al.

Nov 29th, 2021 - This study aimed to explore differences in clinical features and prognosis among patients with varied myeloperoxidase (MPO) antineutrophil cytoplasmic antibody-associated vasculitis (MPO-AAV) associated lung diseases. Patients with MPO-AAV-associa...

see more →

Guidelines  3 results

ACR Appropriateness Criteria® Hemoptysis.
https://doi.org/10.1016/j.jacr.2020.01.043
Journal of the American College of Radiology : JACR; , Olsen KM et. al.

May 7th, 2020 - Hemoptysis, the expectoration of blood, ranges in severity from nonmassive to massive. This publication reviews the literature on the imaging and treatment of hemoptysis. Based on the literature, the imaging recommendations for massive hemoptysis ...

Chinese Expert Recommendation for Diagnosis and Treatment of Massive Hemoptysis.
https://doi.org/10.1159/000502156
Respiration; International Review of Thoracic Diseases; Jin F, Li Q et. al.

Sep 12th, 2019 - Massive hemoptysis is one of emergency and critical diseases of the respiratory system. The definition of massive hemoptysis has always been different in the literature, which often depends on the quantitative estimation of the amount of hemoptysi...

Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumotho...
https://doi.org/10.1164/rccm.201002-0157OC
American Journal of Respiratory and Critical Care Medicine; Flume PA, Mogayzel PJ et. al.

Aug 3rd, 2010 - Cystic fibrosis (CF) is a recessive genetic disease characterized by dehydration of the airway surface liquid and impaired mucociliary clearance. As a result, individuals with the disease have difficulty clearing pathogens from the lung and experi...

see more →

Drugs  16 results see all →

Clinicaltrials.gov  29 results

Efficacy and Safety of Argon Plasma Coagulation in the Treatment of Patients With Hemoptysis Caused by Endobronchial Malignancies
https://clinicaltrials.gov/ct2/show/NCT03625947

Oct 1st, 2021 - Hemoptysis is a challenging symptom which may be frequently related to endobronchial malignancies. Patients with central neoplasms and hemoptysis show a lower median survival than patients with no bleeding and endobronchial neoplasms and/or patien...

Evaluation of Deployment Capability and Accuracy of an Outside the Scope (OTS), Detachable Catheter System for Ablation of Peripheral Lung Lesions: An Ex-Vivo Human Lung Model Study
https://clinicaltrials.gov/ct2/show/NCT04722432

Jul 30th, 2021 - Lung ablative therapies have growing interest in the treatment of early-stage primary lung cancer in surgical high-risk patients and as part of multimodal treatment in patients with large lesions or metastatic malignant disease in the lungs. Endob...

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effu...
https://clinicaltrials.gov/ct2/show/NCT04792970

Jul 22nd, 2021 - Study Activities: Patients will be randomized to either the standard daily drainage group or the talc instilled via tunneled pleural catheter combined with standard daily drainage group. Patients will complete questionnaires regarding their health...

Novel Agents for Treatment of High-risk COVID-19 Positive Patients
https://clinicaltrials.gov/ct2/show/NCT04374019

Jun 30th, 2021 - Coronavirus Disease 2019 (COVID-19) is a highly contagious disease, caused by a novel enveloped RNA beta-coronavirus, also known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The first case of this unprecedented outbreak "pneumo...

Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
https://clinicaltrials.gov/ct2/show/NCT02338440

Mar 30th, 2021 - Primary Objective: To evaluate the pharmacokinetics of lipo-PGE1. Secondary objective: To evaluate the relation between lipo-PGE1 concentration and VOD occurrence, severity. Inclusion criteria Patients undergoing HSCT with high risk of VOD who can...

see more →

News  113 results

Cavitary Lung Lesion in a Tuberculosis-Negative Patient
https://www.mdedge.com/fedprac/article/247212/pulmonology/cavitary-lung-lesion-tuberculosis-negative-patient
LT Michael C. Harding, MD, USPHS, Capt Steven J. Gibson, MD, USAF et. al.

Oct 8th, 2021 - A patient with worsening chronic cough, shortness of breath, and hemoptysis tested negative for tuberculosis; but a chest computed tomography scan showed an upper left lobe cavitary lesion. A 71-year-old, currently homeless male veteran with a 29.

CDC Case Challenge: Four People With Cough and Dyspnea After Attending a Baseball Game
https://www.medscape.com/viewarticle/960314

Oct 7th, 2021 - Disclaimer:  The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention (CDC) or the US Public Health Service.  Editor's Note: Th...

Double Hit: Epstein-Barr Virus Causing Infectious Mononucleosis Followed by Hemolytic Uremic Syndrome
https://www.mdedge.com/fedprac/avaho/article/245913/infectious-diseases/double-hit-epstein-barr-virus-causing-infectious
Oday Elmanaseer, MD ([email protected]), Alzira Avelino, MD et. al.

Sep 9th, 2021 - Introduction Epstein-Barr virus (EBV) is a herpes virus that commonly causes infectious mononucleosis (IM) and linked to different hematological conditions. Here we present a case of EBV-triggered Hemolytic Uremic Syndrome (HUS) with pulmonary inv.

Breast Cancer Management: Monitoring Patients for ILD
https://www.onclive.com/view/breast-cancer-management-monitoring-patients-for-ild

Sep 8th, 2021 - Mark D. Pegram, MD: Interstitial lung disease [ILD] is a diagnosis of exclusion. It’s seen with numerous drugs that we use in breast cancer, such as CDK4/6 inhibitors, everolimus, and trastuzumab deruxtecan. So we are constantly screening for this...

A Rapidly Progressive Thoracic Tumor
https://www.mdedge.com/fedprac/avaho/article/245863/oncology/rapidly-progressive-thoracic-tumor
Tahani Atieh ([email protected]), January Fields-Meehan Kansas City VA Medical Center

Sep 8th, 2021 - Introduction SMARCA4-deficient thoracic sarcomas are a rare entity, first described in 2015 in a study of 19 patients with a median age of 41 years who presented with large compressive masses with frequent infiltration into surrounding tissues [1].

see more →

Patient Education  1 results see all →